Newland Pharmaceutical Co (SZSE:301277) Beginning Cash Position : ¥270.0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Newland Pharmaceutical Co Beginning Cash Position?

Newland Pharmaceutical Co's Beginning Cash Position for the quarter that ended in Mar. 2024 was ¥270.0 Mil.

Newland Pharmaceutical Co's quarterly Beginning Cash Position increased from Sep. 2023 (¥229.7 Mil) to Dec. 2023 (¥259.7 Mil) and increased from Dec. 2023 (¥259.7 Mil) to Mar. 2024 (¥270.0 Mil).

Newland Pharmaceutical Co's annual Beginning Cash Position declined from Dec. 2021 (¥36.3 Mil) to Dec. 2022 (¥30.4 Mil) but then increased from Dec. 2022 (¥30.4 Mil) to Dec. 2023 (¥46.5 Mil).

Newland Pharmaceutical Co Beginning Cash Position Historical Data

The historical data trend for Newland Pharmaceutical Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newland Pharmaceutical Co Beginning Cash Position Chart

Newland Pharmaceutical Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

6.00

19.04

36.33

30.40

46.52

Newland Pharmaceutical Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial											46.52	188.35	229.72	259.68	270.02

Newland Pharmaceutical Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Newland Pharmaceutical Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Newland Pharmaceutical Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Newland Pharmaceutical Co (SZSE:301277) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newland Pharmaceutical Co Ltd (SZSE:301277) » Definitions » Beginning Cash Position

Traded in Other Exchanges

N/A

Address

East side of the south section of Weiwu Road, Henan Province, Changge, CHN, 461500

Website

http://www.newlandpharma.com

Newland Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chiral pharmaceutical intermediates.

Newland Pharmaceutical Co (SZSE:301277) Headlines

No Headlines